BioCardia, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| BCDA | TNYA | LXEO | RNA | RCKT | SLDB | |
|---|---|---|---|---|---|---|
| Market cap | 13.82M | 84.31M | 265.14M | 148.48M | 286.51M | 699.11M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -1.6 | -0.9 | -2.4 | -1.5 | -1.6 | -3.8 |
| Price/book | 5.1 | 1.2 | 1.1 | 0.7 | 0.8 | 2.9 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −28.91% | −73.91% | −62.07% | −41.15% | −19.20% | +54.69% |
| Today | −0.92% | +2.66% | +3.86% | −0.46% | +3.98% | +3.82% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All BCDA news ›J&J data show lower mortality with Impella in HRPCI than CHIP-BCIS3
Real-world and observational findings from 1,379 patients across US and European centres reported decreased mortality than the CHIP-BCIS3 trial. Johnson & Johnson (J&J) has reported findings from three separate clinical analyses…
BioCardia (BCDA) & Its Competitors Head to Head Contrast
Posted by Kim Johansen on Nov 1st, 2026 BioCardia (NASDAQ:BCDA – Get Free Report) is one of 844 publicly-traded companies in the “Biotechnology” industry, but how does it contrast to its rivals? We will compare BioCardia to similar…
Narrative review maps recombinant BNP effects and uncertain clinical outcomes
A 2026 narrative review finds that recombinant human B-type natriuretic peptide rapidly improves hemodynamic and renal measures in acute heart failure and myocardial infarction, while durable clinical benefits remain uncertain. One study…
BioCardia To Provide Update On CardiAMP HF II Study For HfrEF At HFSA Conference
BioCardia Inc. (BCDA), a cellular therapeutics company, on Wednesday reported the upcoming presentation on CardiAMP in treating HFrEF. The data will be presented at the 2026 Annual Scientific Meeting of the Heart Failure Society of America…
Transcript : BioCardia, Inc., Q1 2026 Earnings Call, May 15, 2026
Presentation Operator MessageOperator Ladies and gentlemen, thank you for standing by. Good afternoon, and welcome to the BioCardia 2026 First Quarter Financial Results and Business Update Transcript : BioCardia, Inc., Q1 2026 Earnings…
BioCardia Inc Aligns With FDA On Helix Transendocardial Delivery Catheter Clearance Pathways
BioCardia, Inc. announced the outcome of its Pre-Submission Meeting with FDA on the Helix Transendocardial Delivery Catheter System . FDA agreed that there are two pathways for Helix marketing... announced the outcome of its Pre-Submission…
BioCardia, Inc. Provides Update On PMDA CardiAMP HF Shonin Submission And FDA Helix Pre-Submission
BioCardia, Inc. provided an update on near term milestones. CardiAMP® Autologous Cell Therapy for Ischemic Heart Failure: BioCardia is working towards a Shonin pre-market regulatory submission to... provided an update on near term…
BioCardia says CardiAMP HF II may support FDA approval
3 E Network Signs Core 9 MVA Power Distribution Agreement for Mikkeli AI Compute Center in Finland Disc Medicine Announces Success on All Primary and Secondary Endpoints in the Pivotal Phase 3 APOLLO Trial of Bitopertin in Adults and…
BioCardia Announces FDA Acceptance of De Novo Pre-Submission Package for Helix™ Catheter Marketing Clearance FDA Substantive Review and Meeting Expected this Quarter
3 E Network Signs Core 9 MVA Power Distribution Agreement for Mikkeli AI Compute Center in Finland Disc Medicine Announces Success on All Primary and Secondary Endpoints in the Pivotal Phase 3 APOLLO Trial of Bitopertin in Adults and…
BioCardia Announces FDA Confirms Helix Transendocardial Delivery Catheter Meeting Minutes Supporting Follow-On De Novo Pre-Submission For Approval
BioCardia has received FDA confirmation of the outcome of its Pre-Submission Meeting on the Helix Transendocardial Delivery Catheter System . FDA has reviewed and accepted the meeting minutes provided... BioCardia has received FDA…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com7
- stocktitan.net2
- rttnews.com1
- themarketsdaily.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 11 articles, not a forecast.